+61 7 3176 4400 Level 1, B2 2 Burke St Woolloongabba Qld 4102 Australia

04-Sept-2024

New Report – Queensland Non-Small Cell Lung Cancer Quality Index 2012-2021 This report is presented using optimal care pathways and clinical indicators in lung cancer care. It is a tool for reviewing and comparing information on the safety and quality of NSCLC management in Queensland, including public and private cancer care services and provides a comprehensive view of staging, multidisciplinary team review, access, treatment and outcomes.

Read Article

01-July-2024

We are pleased to share our recent key report which will inform policies, programs and practices to support improved cancer outcomes for Aboriginal and Torres Strait Islander Peoples. This report aims to shed light on cancer incidence, treatment, and outcomes among Aboriginal and Torres Strait Islander Peoples across eight Indigenous regions of Queensland.

Read Article

28-June-2024

Treating people with cancer in Queensland and Victoria: National benchmarking starts here reports on cancer services for each state. This first report builds on analysis already happening in both Queensland and Victoria and focuses on surgical indicators with surgical rates, time to first surgery, mortality and survival examined. These indicators directly affect people with cancer and their clinical outcomes, and measure service delivery for public and private facilities.

Read Article

26-June-2024

Join us in celebrating 20 years if achievements at Cancer Alliance Queensland. We would like to extend our gratitude to all the clinicians and teams who have contributed to our achievements. Your commitment and willingness to embrace new systems have been instrumental in our progress. Together, we will continue to strive towards a future where every person affected by cancer receives the highest quality of care and support.

Read Article

05-Oct-2023

A signing ceremony officiated the joint initiative between Metro South Health (MSH), Cancer Alliance Queensland, the Port Moresby General Hospital, and the School of Medicine and Health Sciences at the University of Papua New Guinea. Cancer Alliance Queensland will assist Papua New Guinea (PNG) establish a national cancer registry and provide web-based software (QOOL-PNG) to enable the capture of incidence and mortality data for the PNG cancer population.

Read Article

14-Mar-2023

This funding will support the establishment of an Australian Brain Cancer Registry (ABCR) to improve quality of life and survival for a cancer group that has not seen any noticeable change in outcomes in decades. With this grant, Brain Cancer Biobanking Australia (BCBA) and project partners, Cancer Alliance Queensland (CAQ) and the Australian e-Health Research Centre at CSIRO, will establish the ABCR by developing infrastructure, natural language processing and a data dictionary to enable the automated electronic collection of the data points required to report Clinical Quality Indicators. CAQ will build on the current clinical application software suite, by developing a new application clinical quality register application known as QOOL-CQR (pronounced seeker). We predict this approach will capture clinical management information for >90% of all brain cancer patients in Australia, approximately 1600 patients per year. CAQ will also create a Registry Trials and Patient Enrolment Portal (RTPEP) that will support patients to participate in research, including randomised trials, and collect outcome data. RTPEP will support storage of genomic data and patient consent for research use of data. This will make clinical trials more available and affordable and will enable future translational research. A third Biobanking and Organoid Platform will be established to standardise national brain cancer biobanking, facilitate linkage of ABCR data to banked samples, and establish national protocols for brain organoid development and screening pipelines to advance translational research. This integrated network of platforms will transform patient care and brain cancer research in Australia, leading to the improvements in survival so long overdue for this cancer group.

Read Article